Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.

Blood reviews - 1 Sept 2002

Bellucci S, Caen J

Abstract excerpt

Glanzmann Thrombasthenia, an exceptional inherited platelet disorder is characterized by a complete lack of platelet aggregation due to a defect in the alpha(IIb)beta(3) complex or to a qualitative abnormality of this complex. Advances in molecular biology have permitted to precise the molecular abnormality on alpha(IIb) or beta(3) genes responsible for the disease and have also contributed to a better knowledge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Management
Share to Hemorrhage
Share to History, 20th Century

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to History, 21st Century

Share to Mutation

Share to Platelet Glycoprotein GPIIb-IIIa Complex

Share to Thrombasthenia

Source

Identifiers

PMID: 12163005
DOI: 10.1016/s0268-960x(02)00030-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.PMID 12163005Read ↗

Biochemical and molecular basis of Glanzmann's thrombasthenia.Semantic proximity Read ↗

Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?Semantic proximity Read ↗

Glanzmann thrombasthenia: state of the art and future directions.Semantic proximity Read ↗

Glanzmann's Thrombasthenia: An OverviewSemantic proximity Read ↗

Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.Semantic proximity Read ↗

Molecular characterization of Glanzmann's thrombasthenia in Iran: identification of three novel mutations.Semantic proximity Read ↗

Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.Semantic proximity Read ↗

Inherited platelet disorders.Semantic proximity Read ↗

Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients.Semantic proximity Read ↗

Inherited disorders of platelets: an update.Semantic proximity Read ↗

Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?Semantic proximity Read ↗

Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.